Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety Study of Nivolumab for Selected Advanced Malignancies in India

NCT03444766 is registered in ClinicalTrials.gov with Bristol-Myers Squibb as lead sponsor.

NCT NCT03444766
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03444766 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety Study of Nivolumab for Selected Advanced Malignancies in India
Lead sponsor
Bristol-Myers Squibb
Phase
Phase 4
Overall status
Completed
Start date
March 6, 2018
Completion date
July 17, 2019
Enrollment
100 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer, kidney neoplasms, non-small cell lung cancer (nsclc), non-small-cell lung carcinoma, nonsmall cell lung cancer, renal cancer, renal neoplasms